14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
GGB vs ABEV: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Ambev S.A. (ABEV) is the stronger overall head-to-head candidate over Gerdau S.A. (GGB) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). GGB carries a Unified Composite Score of 45.5/100 (HOLD) at $4.16 (6.2x Forward P/E, 11.3% operating margin), whereas ABEV carries 40.7/100 (SELL) at $2.61 (12.8x Forward P/E, 26.1% operating margin).
Composite vs. Pillar Nuance: While GGB currently prints a higher short-term Unified Composite Score (45.5/100 HOLD vs. ABEV 40.7/100 SELL), ABEV captures the overall institutional head-to-head verdict (5–5 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (26.1% vs. 11.3% operating margin) and revenue trajectory (+3.6% vs. +3.9% YoY).
Technical & Structure Timing Caution: GGB is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.1); meanwhile ABEV is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GGB vs ABEV. Trailing 12-month operating profitability (GGB 11.3% vs ABEV 26.1%) and valuation multiples (GGB 6.2x vs ABEV 12.8x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Beverages - Brewers value chain with $41.0B market capitalization and 26.1% operating margin.
OpEx & R&D Reinvestment25.7% of Rev ($4.25B)
90D Engineering Disclosures0 Published
Investor FAQ GGB vs ABEV Key Questions & Quantitative Answers
As of Nov 20, 2026, Ambev S.A. (ABEV) is the stronger overall head-to-head candidate over Gerdau S.A. (GGB) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). GGB carries a Unified Composite Score of 45.5/100 (HOLD) at $4.16 (6.2x Forward P/E, 11.3% operating margin), whereas ABEV carries 40.7/100 (SELL) at $2.61 (12.8x Forward P/E, 26.1% operating margin). Composite vs. Pillar Nuance: While GGB currently prints a higher short-term Unified Composite Score (45.5/100 HOLD vs. ABEV 40.7/100 SELL), ABEV captures the overall institutional head-to-head verdict (5–5 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (26.1% vs. 11.3% operating margin) and revenue trajectory (+3.6% vs. +3.9% YoY). Technical & Structure Timing Caution: GGB is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.1); meanwhile ABEV is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
GGB leads the Growth & Scale pillar: GGB posts +3.9% YoY revenue growth and +46.1% YoY earnings growth on $13.7B TTM revenue (14.7% gross margin, 11.3% operating margin), compared with ABEV at +3.6% YoY revenue growth and -9.4% YoY earnings growth on $16.6B TTM revenue (51.8% gross margin, 26.1% operating margin). On trailing 12-month operating scale, GGB generates $13.7B in USD-normalized revenue versus $16.6B for ABEV. In operating R&D and SG&A reinvestment, GGB deploys 3.4% of Rev ($466M) (0 90-day corporate R&D disclosures) versus 25.7% of Rev ($4.25B) (0 disclosures) for ABEV.
GGB screens cheaper on headline valuation multiples. GGB trades at 6.2x Forward P/E, 16.1x Trailing P/E, N/M PEG, and 0.6x EV/Revenue (15.8% EBITDA margin), whereas ABEV trades at 12.8x Forward P/E, 14.0x Trailing P/E, 1.95x PEG, and 2.5x EV/Revenue (30.0% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against GGB (5.0% ROE) versus ABEV (17.6% ROE) capital efficiency.
In options market volatility and institutional positioning, GGB carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.08β · 45% Vol realized risk). By comparison, ABEV carries 13.5% implied volatility (<1st %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.49β · 55% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.